Home / mesothelioma / mesothelioma law firm / Genmab, Novartis leukemia drug Arzerra filed for European approval

Wednesday, July 8, 2015

Genmab, Novartis leukemia drug Arzerra filed for European approval

By Unknown
On

ReutersGenmab, Novartis leukemia drug Arzerra filed for European approvalReutersCOPENHAGEN Novartis submitted an application to the European Medicines Agency (EMA) for the use of ofatumumab, branded as Arzerra, as maintenance therapy for patients with relapsed chronic lymphocytic leukemia, its co-developer Genmab said.and more »

Genmab, Novartis leukemia drug Arzerra filed for European approval Rating: 4.5 Diposkan Oleh: Unknown

Subscribe to: Post Comments (Atom)
 

Top